An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S.

Welcome to the Cipla Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent ...

So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...

India currently imposes a 10% tariff on medicines imported from US. If Donald Trump decides to increase the tariff on Indian ...

Sun Pharma and Dr Reddy’s Lab were among the key index losers that led to the Nifty slipping in early trade.Other pharma ...

The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly ...

The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy’s dropped as much as 4%, and ...

Indian stock markets on Wednesday opened lower despite mixed global cues and uncertainties and US tariff concerns announced ...

Indian stock markets opened lower on Wednesday due to US tariff concerns and mixed global cues. With 788 stocks rising and ...

Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.